# Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults

> **NCT02421367** · PHASE1,PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 140 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** TDENV-PIV with AS03B adjuvant. Placebo: 0.9% Sodium Chloride Solution.

## Key facts

- **NCT ID:** NCT02421367
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-12
- **Final completion:** 2018-03
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2019-09-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02421367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02421367, "Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02421367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*